People usually ask how long saffron takes to work for one of two reasons: mood or sleep. The trials ran for weeks: four for sleep, six to eight for most mood trials, and twelve for the largest. How long a trial ran is not the same as how soon anything changed, and most report their comparison with placebo only at the end. They also found a modest effect, smaller in the newer and larger trials than in the early ones. Here is what each study measured, and when.

This article is educational and is not medical advice. Saffron is not a substitute for treatment for depression or anxiety. If you take an antidepressant, talk to your prescriber or pharmacist before adding saffron. If you are thinking about suicide or are in crisis, call or text 988 in Canada or the U.S., any time. If your safety is at risk right now, call 911.

The short answer

For sleep, a change may come within the first week or two: in the one sleep trial that measured weekly, most of the improvement on saffron came in the first seven days. The trials still ran about four weeks, so that is a fair point to judge it. For mood, plan on six to eight weeks. Some mood trials checked along the way and some only at the end, but they report their comparison with placebo at the end of the trial, so they don't pin down when a difference first appeared. In several, people on placebo also improved a lot. One small laboratory study tested a single dose against a stress test, but that is not the same as everyday mood.

What a single dose has shown

In a crossover study of 19 healthy young men, a single 30 mg dose of a saffron extract, a dose of safranal (one of saffron's aroma compounds) or a placebo was given under the tongue 13 minutes before a laboratory stress test. Self-rated stress was lower after both saffron products than after placebo, but in the pairwise comparisons only safranal differed significantly. The extract delayed the peak of the stress hormone cortisol (Pouchieu 2023). Three of the authors worked for the extract's manufacturer, which supplied the products. The study shows something measurable within the hour in a lab, with a preparation taken under the tongue. It does not show what an ordinary swallowed capsule does on an ordinary day.

Mood: four to twelve weeks

The shortest mood trial we found ran four weeks. In 128 adults with low mood but no diagnosis, 28 mg a day of a branded extract (affron) improved a mood questionnaire more than placebo, while 22 mg a day did not (Kell 2017). Mood was measured only at the start and after four weeks, and one author worked for the extract's maker.

Several trials ran six weeks, with mixed results. In 40 adults with mild to moderate major depression, 30 mg a day of saffron did better than placebo on a clinician-rated depression scale at six weeks (Akhondzadeh 2005). A 2025 French trial led by the public research institute INRAE, in 51 healthy adults with mild symptoms found no effect on its main measure, a combined score for depression, anxiety and fatigue, after six weeks; one secondary score for perceived mental health improved (Amadieu 2025).

The longer trials ran eight to twelve weeks. In 68 teenagers with mild to moderate anxiety or low mood who finished an eight-week trial, the teens' own reports improved more with saffron than with placebo, but their parents' reports mostly did not (Lopresti 2018). The largest trial to date gave 202 adults with low mood 28 mg a day or a placebo for twelve weeks. Depression scores improved more with saffron, a modest effect, and 72% of the saffron group had a meaningful drop compared with 54% on placebo. Anxiety, stress, sleep and wellbeing scores did not differ between the groups (Lopresti 2025). That trial was funded by the extract's manufacturer, two of whose employees were authors.

The most recent review of the trials, 34 of them with 1,769 adults, all lasting at least four weeks, found that saffron lowered self-rated depression and anxiety scores. The clinician-rated scales did not change, and the results varied widely from trial to trial (Mahmoudi 2026). That is a reason to expect a modest effect at best, and to judge it over weeks rather than days.

Get The Signal by email. New research, grade changes and safety notes, about every two weeks. Subscribe free

Sleep: an early change, judged over about four weeks

The sleep trials are shorter, and one of them measured every week. In 63 adults with self-reported poor sleep, 14 mg of affron twice a day improved insomnia and sleep-quality scores more than placebo over 28 days. Insomnia scores were taken weekly, and in the saffron group most of the drop came between the start and day 7, with no significant further change after that; the placebo group's scores did not change significantly over the four weeks (Lopresti 2020). The comparison with placebo used the average of the weekly scores, so the trial does not show that saffron beat placebo at day 7 itself, and it was funded by the extract's manufacturer. A second 28-day trial in 120 adults gave 14 mg or 28 mg an hour before bed: sleep-quality ratings improved more than with placebo, similarly at both doses, but most of the other sleep measures did not differ (Lopresti 2021). A four-week pilot in 52 adults aged 55 to 85, using 30 mg a day of a different extract, reported better self-rated sleep and faster sleep onset on a sleep tracker (Lang 2025).

Another trial checked at the halfway point and saw less. In 66 adults with mild to moderate sleep problems, people on saffron and on placebo had improved about equally on most sleep questionnaires by week three. By week six, the saffron group differed from the placebo group on only a few measures, such as time in bed on a wrist sleep tracker (Pachikian 2021). A supplier of saffron extract funded that trial. Taken together: a sleep change may show up early, the placebo response can be large early on too, and the trials judged the result over four to six weeks.

What to expect, week by week

  • Day one: no trial has measured an effect on everyday mood or sleep from a single dose. The one single-dose study used a laboratory stress test.
  • Week 1: in the one sleep trial that measured weekly, most of the improvement on saffron came in the first seven days. Placebo groups can improve early too.
  • Weeks 2 to 3: in a second sleep trial that checked at week three, the placebo group had improved about as much as the saffron group.
  • Week 4: the end of the sleep trials and of the shortest mood trial that reported a benefit, a fair point to judge it for sleep.
  • Weeks 6 to 8: the length of most mood trials, with mixed results. A six-week French trial found no effect on its main measure.
  • Week 12: the length of the largest trial, which found a modest effect on depression scores and none on anxiety, stress or sleep.
  • Beyond 12 weeks: little data. Review with a clinician whether it is worth continuing.

Before you think about timing: who should be careful

  • Anyone taking an antidepressant. Saffron has been studied as an add-on to antidepressants, but check with your prescriber first. Our article on saffron and antidepressants covers what is known.
  • Pregnancy or breastfeeding: avoid it unless your clinician advises otherwise. At high doses saffron can stimulate the uterus.
  • Bipolar disorder: talk to your clinician before taking anything aimed at mood.
  • Low mood that lasts more than two weeks, or that affects work, sleep or relationships, is worth raising with a doctor rather than waiting out a supplement trial.

If you decide to try it

  • Most trials used 28 to 30 mg a day of a standardized extract, taken once a day or split into two doses. A pinch of cooking saffron provides far less.
  • Note how you feel or sleep before you start, so you have something to compare against.
  • Judge it at about four weeks for sleep and six to eight weeks for mood, not day to day, even if you notice a change sooner.
  • If nothing has changed by then, it is reasonable to conclude it isn't helping and to stop.
  • Tell your doctor or pharmacist you take it, and mention it whenever a new medication is prescribed.

The bottom line

Saffron is not a same-day effect. One sleep trial saw most of its change in the first week, but the sleep studies ran about four weeks and the mood studies six to twelve, the mood trials report their placebo comparisons at the end, and the newer, larger trials found smaller effects than the early ones, with big placebo responses alongside. If you try it, give it four to eight weeks before deciding, and don't use it in place of treatment for depression.

Evidence grade, studied doses, cautions and the references behind them, in one place. See the full saffron profile

References

  • Pouchieu C, Pourtau L, Brossaud J, et al. "Acute effect of a saffron extract (Safr'Inside) and its main volatile compound on the stress response in healthy young men: a randomized, double blind, placebo-controlled, crossover study." Nutrients, 2023;15(13):2921. PMID: 37447245.
  • Kell G, Rao A, Beccaria G, et al. "affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial." Complementary Therapies in Medicine, 2017;33:58–64. PMID: 28735826.
  • Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. "Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial." Phytotherapy Research, 2005;19(2):148–151. PMID: 15852492.
  • Amadieu C, Leyrolle Q, Farneti M, et al. "Effect of saffron extract supplementation on mood in healthy adults with subclinical symptoms of depression: a randomized, double-blind placebo-controlled study." American Journal of Clinical Nutrition, 2025;122(6):1625–1635. PMID: 41047129.
  • Lopresti AL, Drummond PD, Inarejos-García AM, Prodanov M. "affron®, a standardised extract from saffron (Crocus sativus L.) for the treatment of youth anxiety and depressive symptoms: a randomised, double-blind, placebo-controlled study." Journal of Affective Disorders, 2018;232:349–357. PMID: 29510352.
  • Lopresti AL, Smith SJ, Marx W, et al. "An examination into the effects of a saffron extract (Affron) on mood and general wellbeing in adults experiencing low mood: a randomized, double-blind, placebo-controlled trial." Journal of Nutrition, 2025;155(7):2300–2311. PMID: 40414301.
  • Mahmoudi R, Mohammadi-Sartang M, Servatyari K, Rafieipour N. "Effect of saffron on depression, anxiety and mood disorder: a GRADE assessed systematic review and meta-analysis of 34 randomized controlled trials." Nutritional Neuroscience, 2026;29(7):816–837. PMID: 41693488.
  • Lopresti AL, Smith SJ, Metse AP, Drummond PD. "Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial." Journal of Clinical Sleep Medicine, 2020;16(6):937–947. PMID: 32056539.
  • Lopresti AL, Smith SJ, Drummond PD. "An investigation into an evening intake of a saffron extract (affron®) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep: a randomised, double-blind, placebo-controlled, multi-dose study." Sleep Medicine, 2021;86:7–18. PMID: 34438361.
  • Lang L, Ditton A, Stanescu A, et al. "A standardised saffron extract improves subjective and objective sleep quality in healthy older adults with sleep complaints: results from the gut-sleep-brain axis randomised, double-blind, placebo-controlled pilot study." Food & Function, 2025;16(17):6817–6832. PMID: 40762630.
  • Pachikian BD, Copine S, Suchareau M, Deldicque L. "Effects of saffron extract on sleep quality: a randomized double-blind controlled clinical trial." Nutrients, 2021;13(5):1473. PMID: 33925432.